Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Inoue

Showing results (131-140 of 158) with videos related to

Pageof 16
Sort By:
Open Heart|April 10, 2025
Prevalence of ventricular parasystole in patients with cardiac sarcoidosis: correlation between parasystole and inflammation in ventricular fibrillationTakashi Ikee, Kenzaburo Nakajima, Kohei Ishibashi, et al.
JACC. Asia|December 14, 2023
Fatal Arrhythmic Risks in Cardiac Sarcoidosis With Mildly Impaired Cardiac FunctionHiroyuki Kamada, Kohei Ishibashi, Yuichiro Miyazaki, et al.
Circulation Reports|October 11, 2024
Elevated B-Type Natriuretic Peptide Level as a Residual Risk Factor for Ventricular Arrhythmias Among Patients Undergoing Cardiac Resynchronization Therapy With Improved Left Ventricular Ejection FractionJunichi Kamoshida, Nobuhiko Ueda, Kohei Ishibashi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 6, 2023
Clinical Significance of Atrial Tachyarrhythmia Duration for Ventricular Arrhythmia in Patients With Cardiac Resynchronization TherapyNobuhiko Ueda, Takashi Noda, Koshiro Kanaoka, et al.
Journal of Medical Virology|January 26, 2011
Amino acid substitution in the core protein has no impact on relapse in hepatitis C genotype 1 patients treated with peginterferon and ribavirinYuko Inoue, Naoki Hiramatsu, Tsugiko Oze, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 14, 2026
Trends and In-Hospital Outcomes of Conventional Transvenous Pacemaker vs. Leadless Pacemaker - Nationwide Matched Control Study Using the JROAD-DPC DatabaseTakuya Nishimura, Koshiro Kanaoka, Yoko Sumita, et al.
Heart Rhythm O2|March 30, 2026
Difference in the efficacy of atrial antitachycardia pacing for suppression of ventricular arrhythmiasNobuhiko Ueda, Takashi Noda, Toshihiro Nakamura, et al.
Journal of Gastroenterology|August 23, 2011
Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case-control studyNaoki Hiramatsu, Yuko Inoue, Tsugiko Oze, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 24, 2007
Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudineNao Kurashige, Naoki Hiramatsu, Kazuyoshi Ohkawa, et al.
Heart (British Cardiac Society)|February 9, 2022
Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1Keiko Shimamoto, Seiko Ohno, Koichi Kato, et al.
Pageof 16

Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
Open Heart|April 10, 2025
Prevalence of ventricular parasystole in patients with cardiac sarcoidosis: correlation between parasystole and inflammation in ventricular fibrillationTakashi Ikee, Kenzaburo Nakajima, Kohei Ishibashi, et al.
JACC. Asia|December 14, 2023
Fatal Arrhythmic Risks in Cardiac Sarcoidosis With Mildly Impaired Cardiac FunctionHiroyuki Kamada, Kohei Ishibashi, Yuichiro Miyazaki, et al.
Circulation Reports|October 11, 2024
Elevated B-Type Natriuretic Peptide Level as a Residual Risk Factor for Ventricular Arrhythmias Among Patients Undergoing Cardiac Resynchronization Therapy With Improved Left Ventricular Ejection FractionJunichi Kamoshida, Nobuhiko Ueda, Kohei Ishibashi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 6, 2023
Clinical Significance of Atrial Tachyarrhythmia Duration for Ventricular Arrhythmia in Patients With Cardiac Resynchronization TherapyNobuhiko Ueda, Takashi Noda, Koshiro Kanaoka, et al.
Journal of Medical Virology|January 26, 2011
Amino acid substitution in the core protein has no impact on relapse in hepatitis C genotype 1 patients treated with peginterferon and ribavirinYuko Inoue, Naoki Hiramatsu, Tsugiko Oze, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 14, 2026
Trends and In-Hospital Outcomes of Conventional Transvenous Pacemaker vs. Leadless Pacemaker - Nationwide Matched Control Study Using the JROAD-DPC DatabaseTakuya Nishimura, Koshiro Kanaoka, Yoko Sumita, et al.
Heart Rhythm O2|March 30, 2026
Difference in the efficacy of atrial antitachycardia pacing for suppression of ventricular arrhythmiasNobuhiko Ueda, Takashi Noda, Toshihiro Nakamura, et al.
Journal of Gastroenterology|August 23, 2011
Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels: a matched case-control studyNaoki Hiramatsu, Yuko Inoue, Tsugiko Oze, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 24, 2007
Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudineNao Kurashige, Naoki Hiramatsu, Kazuyoshi Ohkawa, et al.
Heart (British Cardiac Society)|February 9, 2022
Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1Keiko Shimamoto, Seiko Ohno, Koichi Kato, et al.
Pageof 16